Integration of the Therapeutic Workplace in Drug Court

Status Completed

Clinical Trial Summary

Drug Courts were developed as a therapeutic alternative to incarceration of drug-involved offenders by providing 'judicially supervised' drug abuse treatment and probation for nonviolent offenders in lieu of criminal prosecution and incarceration. Outcome studies have shown that drug courts have modest effects on participation in drug abuse treatment, drug use, and employment. The Therapeutic Workplace intervention is an effective employment-based treatment that integrates abstinence reinforcement contingencies in a work setting, intended to treat individuals with histories of drug addiction and chronic unemployment. Under this intervention, drug abuse patients are hired and paid to work. To promote abstinence, patients are required to provide drug-free urine samples to gain and maintain daily access in the workplace. In this way, patients can work and earn salary, but only as long as they remain drug abstinent. Patients using drugs and lacking job skills participate in an initial training phase to initiate abstinence and establish computer data entry skills. Once abstinent and skilled, patients are hired into an income-producing Therapeutic Workplace data entry business. Given that many drug court participants suffer from long histories of drug addiction and unemployment, the Therapeutic Workplace could be ideal for this population. This proposes of this clinical trial is to evaluate the Therapeutic Workplace intervention in a Drug Court.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00607360
Study type	Interventional
Source	National Institute on Drug Abuse (NIDA)
Contact
Status	Completed
Phase	Phase 1
Start date	August 2004
Completion date	July 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT02939352` - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues	Early Phase 1
Completed	`NCT02437123` - The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs	N/A
Completed	`NCT02224508` - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks	N/A
Completed	`NCT02192931` - A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users	Phase 4
Completed	`NCT01685073` - The Role of Sleep in the Treatment of Cannabis Use Disorders	Phase 2/Phase 3
Completed	`NCT01591239` - Home-Based Program to Help Parents of Drug Abusing Adolescents	N/A
Completed	`NCT00317460` - Buprenorphine and Integrated HIV Care	Phase 4
Completed	`NCT03678051` - CBT4CBT for Women in Residential Treatment for Substance Use Disorders	N/A
Completed	`NCT04105621` - Westlake Personalized Nutrition and Health Cohort for Drug Addicts
Withdrawn	`NCT05440721` - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification	N/A
Completed	`NCT03694327` - Innovative Digital Therapeutic for Smoking Cessation	N/A
Completed	`NCT00390559` - Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3	N/A
Completed	`NCT00244699` - Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth	N/A
Completed	`NCT00496990` - Treating the Partners of Drug Using Pregnant Women: Stage II	Phase 2/Phase 3
Completed	`NCT03411265` - RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing	N/A
Completed	`NCT03402672` - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users	N/A
Completed	`NCT01003496` - Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial	Phase 3
Completed	`NCT02091284` - Bilateral Prefrontal Modulation in Alcoholism	N/A
Completed	`NCT02091167` - Bilateral Prefrontal Modulation in Crack-cocaine Addiction	Phase 2